Radiation therapy in the hypofractionation mode on the Halcyon elite linear accelerator: the first experience of St. Petersburg city clinical oncology dispensary
https://doi.org/10.62546/3034-1477-2024-2-2-23-28
Abstract
Stereotactic radiation therapy in the hypofractionation mode is a method in which high doses of ionizing radiation (more than 3 Gy per fraction) are delivered in a small number of fractions (from 2 to 5). Treatment and the process of preparation for it are carried out using special fixing devices, dosimetric planning techniques of high conformity, with control of the treatment position using x-ray imaging. which makes it possible to ensure the required irradiation accuracy. The advantages are a shorter course of treatment compared to standard fractionation, a high biologically effective dose, a reduced effect of tumor repopulation, greater efficiency under hypoxic conditions, and satisfactory results when irradiating radioresistant tumors. The article presents clinical cases of the use of hypofractionation modes on the Halcyon elite linear accelerator.
About the Authors
E. N. Nikolaeva
City Clinical Oncology Dispensary
Russian Federation
Russian Federation
Nikolaeva Ekaterina Nikolaevna — MD, Ch. radiotherapy specialist
198255, St. Petersburg, Veteranov Ave, 56
E. I. Filatova
City Clinical Oncology Dispensary
Russian Federation
Russian Federation
Filatova Elena Ivanovna — Candidate of Medical Sciences, Associate Professor, Head of Department No. 14
198255, St. Petersburg, Veteranov Ave, 56
A. A. Makulova
City Clinical Oncology Dispensary
Russian Federation
Russian Federation
Makulova Aliya Aivarovna — medical physicist
198255, St. Petersburg, Veteranov Ave, 56
R. V. Orlova
City Clinical Oncology Dispensary ; St. Petersburg State University
Russian Federation
Russian Federation
Orlova Rashida Vakhidovna — Doctor of Medical Sciences, Prof., Head. Department of Oncology; Ch. clinical oncology specialist
Author ID 401170
198255, St. Petersburg, Veteranov Ave, 56
References
1. Timmerman R. D., Herman J., Cho L. C. Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice // J. Clin. Oncol. 2014. Vol. 32. P. 2847–2854.
2. Rodin D., Tawk B., Osama M. Hypofractionated radiotherapy in the real-world setting: An international ESTRO-GIRO survey // Radiother. Oncol. 2021. Apr. Vol. 157. Р. 32–39. doi: 10.1016/j.radonc.2021.01.003. Epub 2021 Jan 14.
3. Gouveia A.G., Chan D.C.W., Hoskin P.J. et al. Advances in radiotherapy in bone metastases in the context of new target therapies and ablative alternatives: A critical review // Radiother. Oncol. 2021. Oct; Vol. 163. Р. 55–67. doi: 10.1016/j.radonc.2021.07.022. 2021 Jul 29. PMID: 34333087 doi: 10.1016/j.radonc.2021.07.
4. Karam I., Yao M., Heron D.E. et al. Survey of current practices from the International Stereotactic Body Radiotherapy Consortium for head and neck cancers // Future oncology. 2017. Vol. 13. P. 603–613.
5. Widmark А., Gunnlaugsson A., Beckman L. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non- inferiority, phase 3 trial // Lancet. 2019. Aug. 3; Vol. 394, No. 10196. Р. 385–395. doi: 10.1016/S0140-6736(19)31131-6. Epub 2019 Jun 18. PMID: 31227373 DOI: 10.1016/S0140-6736(19)31131-6.
6. Lo Greco M.Ch., Giulia M., Marano G. Hypofractionated Radiotherapy in Localized, Low-Intermediate-Risk Prostate Cancer: Current and Future Prospectives // Medicina (Kaunas). 2023. Jun. 14. Vol. 59, No. 6. Р. 1144. doi: 10.3390/medicina59061144. PMID: 37374348 PMCID: PMC10301277 DOI: 10.3390/medicina59061144.
7. Gerasimov V.A., Boldyreva V.V., Datsenko P.V. Hypofractionation for glioblastomas: changing the paradigm of radiation treatment. Issues of neurosurgery named after N. N. Burdenko, 2017, Vol. 81, No. 6, pp. 116–124 (In Russ.). https://doi.org/10.17116/neiro2017816116-124.
8. Arsenyev A.I., Novikov S.N., Kanaev S.V. еt al. Radiobiology of high-dose radiation therapy: a textbook for students in the system of higher and additional professional education. St. Petersburg: Publishing house of the National Medical Research Center of Oncology named after N.N. Petrova, 2022. 156 p. (In Russ.). ISBN 978-5-6048249-0-0.
9. Sokurenko V.P., Karpenko A.V., Lushchaeva T.A., Ponezha T.E. Head and neck tumors: adjuvant radiation therapy in hypofractionation mode. Diagnostic radiology and radiotherapy, 2022, Vol. 13, No. 4, pp. 115–123 (In Russ.). https://doi.org/10.22328/2079-5343-2022-13-4-115-123.
10. Dengina N.V., Mitin T.V., Timofeev I.V., Usychkin S.V. Radiation therapy for oligometastatic cancer. Malignant tumors, 2020, Vol. 10, No. 3, pp. 5–14 (In Russ.).
Review
For citations:
Nikolaeva E.N., Filatova E.I., Makulova A.A., Orlova R.V. Radiation therapy in the hypofractionation mode on the Halcyon elite linear accelerator: the first experience of St. Petersburg city clinical oncology dispensary. Clinical Case in Oncology. 2024;2(2):23-28. (In Russ.) https://doi.org/10.62546/3034-1477-2024-2-2-23-28
Views:
148
Email this article 